First trimester medical termination of pregnancy: An alternative for New Zealand women

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 46, Issue 3, 2006, Pages 193-198

  Goodyear Smith, Felicity ^a,b   Knowles, Alison ^a   Masters, Jonathan ^a  

^a Auckland Medical Aid Centre   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Abortion; Induced abortion; Mifepristone; Therapeutic

Indexed keywords

COCODAMOL; CODEINE; DICLOFENAC; FENTANYL; MIFEPRISTONE; MISOPROSTOL; NAPROXEN; NITROUS OXIDE PLUS OXYGEN; PARACETAMOL; PETHIDINE;

ADULT; AGE; ANALGESIA; ARTICLE; BLEEDING; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; ETHNOLOGY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MEDICAL AUDIT; NEW ZEALAND; NULLIPARA; OUTCOME ASSESSMENT; PAIN; PATIENT SAFETY; PREGNANCY TERMINATION; PRIORITY JOURNAL;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; CHILD; FEMALE; HUMANS; MEDICAL AUDIT; MEDICAL RECORDS; MIFEPRISTONE; NEW ZEALAND; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES;

EID: 33745933499     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2006.00575.x     Document Type: Article

References (15)

1. Abortion Advisory Committee. Report of the Abortion Advisory Committee for 2004. Wellington, New Zealand: Department of Courts, 2004.
2. Royal College of Obstetricians and Gynaecologists. National Evidence-Based Clinical Guidelines: The Care of Women Requesting Induced Abortion. London: Royal College of Obstetricians and Gynaecologists, 2004.
3. Papp C, Schatz F, Krikun G, Hausknecht V, Lockwood CJ. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium. Early Pregnancy 2000; 4: 230-239.
4. Radestad A, Thyberg J, Christensen NJ. Cervical ripening with mifepristone (RU 486) in first trimester abortion. An electron microscope study. Hum Reprod 1993; 8: 1136-1142.
5. Baulieu EE. Contragestion by antiprogestin: A new approach to human fertility control. Ciba Found Symp 1985; 115: 192-210.
6. Ulmann A, Silvestre L, Chemama L et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16 369 women. Acta Obstet Gynecol Scand 1992; 71: 278-283.
7. Sparrow MJ. A woman's choice. Aust N Z J Obstet Gynaecol 2004; 44: 88-92.
8. Janssen CA. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Eur J Obstet Gynecol Reprod Biol 1996; 70: 21-22.
9. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol 2001; 98 (5 Part 1): 806-814.
10. Morgentaler H. Report on 5641 outpatient abortions by vacuum suction curettage. Can Med Assoc J 1973; 109: 1202-1205.
11. Wyatt KM, Dimmock PW, Walker TJ, O'Brien PM. Determination of total menstrual blood loss. Fertil Steril 2001; 76: 125-131.
12. Shand C, Rose S, Simmons A, MJ S. Introduction of early medical abortion in New Zealand: An audit of the first 67 cases. Aust N Z J Obstet Gynaecol 2005; 45: 316-320.
13. Creinin MD. Medical abortion regimens: Historical context and overview. Am J Obstet Gynecol 2000; 183: S3-S9.
14. Macisaac L, Darney P. Early surgical abortion: An alternative to and backup for medical abortion. Am J Obstet Gynecol 2000; 183: S76-S83.
15. National Health and Medical Research Council. When Does Quality Assurance in Health Care Require Independent Ethical Review? Commonwealth of Australia: NHMRC, 20 February 2003.